Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 335-339

  Visca, Paolo ^a   Sebastiani, Valeria ^b   Pizer, Ellen S ^c   Botti, Claudio ^a   De Carli, Piero ^a   Filippi, Stefania ^a   Monaco, Simona ^b   Alo, Piero L ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bladder; Carcinoma; FAS; GLUT1; Prognosis

Indexed keywords

ACETYL COENZYME A; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER 1; MALONYL COENZYME A; MEMBRANE PROTEIN; PALMITIC ACID; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; ENZYME MECHANISM; FOLLOW UP; GENE EXPRESSION; GLUCOSE TRANSPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ANALYSIS OF VARIANCE; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FATTY ACID SYNTHETASE COMPLEX; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 0344405740     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer Statistics 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Vercelli M, Quaglia A, Parodi S and Crosignani P: Cancer prevalence in the elderly. ITAPREVAL Working Group. Tumori 85(5): 391-399, 1999.
3. Otto T, Bex A, Schmidt U et al: Improved prognosis assessment for patients with bladder carcinoma. Am J Pathol 150(6): 1919-1923, 1997.
4. Ro JY, Staerkel GA and Ayala AG: Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am 19: 435-453, 1992.
5. Heney NM: Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 19(3): 429-433, 1992.
6. Badalament RA, Ortolano V and Burgers JK: Recurrent or aggressive bladder cancer. Indications for adjuvant intravescical therapy. Urol Clin North Am 19(3): 485-498, 1992.
7. Wakil SJ: Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28(11): 4523-4530,1989.
8. Roncari DA: Mammalian fatty acid synthetase. I. Purification and properties of human liver complex. Can J Biochem 52(3): 221-230, 1974.
9. Thompson BJ and Smith S: Biosynthesis of fatty acids by lactating human breast epithelial cells: an evaluation of the contribution to the overall composition of human milk fat. Pediatr Res 19(1): 139-143, 1985.
10. Alò PL, Visca P, Marci A, Mangoni A, Botti C and Di Tondo U: Expression of fatty acid synthase as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77: 474-482, 1996.
11. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack FR, Kuhajda FP and Hamilton SR: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150: 201-208, 1997.
12. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR and Kurman RJ: Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 83(3): 528-537, 1987.
13. Mueckler M: Facilitative glucose transporters Eur J Biochem 219(3): 713-725, 1998.
14. Cornford EM, Hyman S and Swartz BE: The human brain GLUT1 glucose transporter ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab 14(1): 106-112, 1994.
15. Zhang JZ and Ismail-Beigi F: Activation of GLUT1 glucose transporter in human erythrocytes. Arch Bioch Biophys 356(1): 86-92, 1998.
16. Jansson T, Wennegren M and Illsley NP: Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metabol 77(6): 1554-1562, 1993.
17. Wolf HJ and Desoye G: Immunohistochemical localization of glucose transporters and insulin receptors in human fetal membranes at term. Histochemistry 100(5): 379-385, 1993.
18. Younes M, Brown RW, Mody DR, Fernandez L and Laucirica R: GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 15(6B): 2895-2898, 1995.
19. Nagase Y, Takata K, Moriyama N, Aso Y, Murakami T and Hirano H: Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 153(3Pt 1): 798-801, 1995.
20. Ito T, Takaki I, Noguchi Y, Satoh S, Hayashi H, Inayama Y and Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade and tumor stage. Mod Pathol 11(5):437-443, 1998.
21. th edition. Philadelphia: Lippincott Raven 1998.
22. Mostofi FK, Sobin LH and Torloni H: Histological typing of urinary bladder tumours. International classification of tumours 19. World Health Organization. Geneva, 1973.
23. Kuhajda FP, Katumuluwa AI and Pasternack GR: Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc Natl Acad Sci USA 86(4): 1188-1192,1989.
24. Alo PL, Visca P, Mazzaferro S, Eleuteri Serpieri D, Mangoni A, Botti C, Monaco S, Carboni M, Zaraca F, Trombetta G and Di Tondo U: Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen and p53 expression in hyperplastic parathyroids. Ann Diagn Pathol 3(5): 287-293, 1999.
25. Visca P, Alo PL, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi S, Di Tondo U and Donnorso RP: Immunohistochemical expression of fatty acid synthase (FAS), apoptotic regulating genes, proliferating factors and ras protein product in colorectal adenomas, carcinomas and adjacent non neoplastic mucosa. Aspects of carcinogenesis and prognostic significance. Clin Cancer Res 5(12): 4111-4118, 1999.
26. Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, Elueteri Serpieri D and Di Tondo U: Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7: 1383-1388, 2000.
27. Isselbacher KJ: Sugar and amino acid transport by cells in culture -differences between normal and malignant cells. N Engl J Med 286(17): 929-933, 1972.
28. Merrall NW, Plevin R and Gould GW: Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal 5(6): 667-675, 1993.
29. Shah SW, Zhao H, Low SY, McArdle HJ and Hundal HS: Characterization of glucose transport and glucose transporters in the human choriocarcinoma cell line BeWo. Placenta 20(8): 651-659, 1999.
30. Noguchi Y, Marat D, Saito A, Yoshikawa T, Doi C, Fukuzawa K, Tsuburaya A, Satoh S and Ito T: Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology 46(28): 2683-2689, 1999.
31. Baer SC, Casaubon L and Younes M: Expression of the human erythrocyte glucose transporter GLUT1 in cutaneous neoplasia. J Am Acad Dermatol 37(4): 575-577, 1997.
32. Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C and Burstein DE: Immunohistochemical staining of GLUT1 in benign, hyperplastic and malignant endometrial epithelia. Cancer 88(12): 2774-2781, 2000.
33. Younes M, Juarez D, Lechago LV and Lerner SP: Glut1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21(1B): 575-578, 2001.
34. Gabrielson EW, Pinn ML, Testa JR and Kuhajda FP: Increased Fatty Acid Synthase is a therapeutic target in mesothelioma. Clin Cancer Res 7: 153-157, 2001.
35. Pizer ES, Chrest FJ, Di Giuseppe JA and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58: 4611-4615, 1998.